US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
FR2413974A1
(fr)
|
1978-01-06 |
1979-08-03 |
David Bernard |
Sechoir pour feuilles imprimees par serigraphie
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
US4681581A
(en)
|
1983-12-05 |
1987-07-21 |
Coates Fredrica V |
Adjustable size diaper and folding method therefor
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US5776093A
(en)
|
1985-07-05 |
1998-07-07 |
Immunomedics, Inc. |
Method for imaging and treating organs and tissues
|
US4735210A
(en)
|
1985-07-05 |
1988-04-05 |
Immunomedics, Inc. |
Lymphographic and organ imaging method and kit
|
US5101827A
(en)
|
1985-07-05 |
1992-04-07 |
Immunomedics, Inc. |
Lymphographic and organ imaging method and kit
|
US4738681A
(en)
*
|
1985-07-10 |
1988-04-19 |
Harrington Arthritis Research Center |
Femoral-joint prosthetic device
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
WO1988001513A1
(en)
|
1986-08-28 |
1988-03-10 |
Teijin Limited |
Cytocidal antibody complex and process for its preparation
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5648471A
(en)
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
WO1991000360A1
(en)
|
1989-06-29 |
1991-01-10 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
US5102990A
(en)
|
1989-08-09 |
1992-04-07 |
Rhomed Incorporated |
Direct radiolabeling of antibodies and other proteins with technetium or rhenium
|
US5605690A
(en)
*
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
US5370870A
(en)
*
|
1989-10-06 |
1994-12-06 |
Genentech, Inc. |
Method for protection against reactive oxygen species
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
WO1991010741A1
(en)
|
1990-01-12 |
1991-07-25 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
US6075181A
(en)
*
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
US5364839A
(en)
|
1990-06-18 |
1994-11-15 |
Genetics Institute, Inc. |
Osteoinductive pharmaceutical formulations
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
DE69133557D1
(de)
|
1990-08-29 |
2007-03-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5194594A
(en)
|
1990-09-07 |
1993-03-16 |
Techniclone, Inc. |
Modified antibodies
|
WO1992010210A1
(en)
|
1990-12-14 |
1992-06-25 |
E.I. Du Pont De Nemours And Company |
Inhibition of angiogenesis by il-1
|
US5206023A
(en)
|
1991-01-31 |
1993-04-27 |
Robert F. Shaw |
Method and compositions for the treatment and repair of defects or lesions in cartilage
|
JPH06507398A
(ja)
|
1991-05-14 |
1994-08-25 |
リプリジェン コーポレーション |
Hiv感染治療のための異種複合抗体
|
WO1992022670A1
(en)
|
1991-06-12 |
1992-12-23 |
Genpharm International, Inc. |
Early detection of transgenic embryos
|
AU2235992A
(en)
|
1991-06-14 |
1993-01-12 |
Genpharm International, Inc. |
Transgenic immunodeficient non-human animals
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
KR100252547B1
(ko)
|
1991-09-05 |
2000-09-01 |
프레드 마리얀스키 |
폴리-또는 올리고누클레오티드의 세포로의 표적화된 전달
|
US5273033A
(en)
*
|
1991-09-19 |
1993-12-28 |
Murray Electronics Associates Limited Partnership |
Electrical stimulation for treatment of osteoarthritis
|
US5716805A
(en)
*
|
1991-10-25 |
1998-02-10 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
ATE208374T1
(de)
|
1992-02-18 |
2001-11-15 |
Otsuka Kagaku Kk |
Beta-laktam und cepham verbindungen und ihre herstellung
|
US5233409A
(en)
|
1992-02-25 |
1993-08-03 |
Schwab Karl W |
Color analysis of organic constituents in sedimentary rocks for thermal maturity
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
AU4231393A
(en)
*
|
1992-05-08 |
1993-12-13 |
Genentech Inc. |
Antibodies to leukemia inhibitory factor
|
NZ253943A
(en)
|
1992-06-18 |
1997-01-29 |
Genpharm Int |
Transfering polynucleotides into eukaryotic cells using co-lipofection complexes of a cationic lipid and the polynucleotide
|
GB9214857D0
(en)
|
1992-07-13 |
1992-08-26 |
Medical Res Council |
Human nucleic acid fragments and their use
|
CA2140638C
(en)
|
1992-07-24 |
2010-05-04 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
EP0752248B1
(en)
|
1992-11-13 |
2000-09-27 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
US5536637A
(en)
*
|
1993-04-07 |
1996-07-16 |
Genetics Institute, Inc. |
Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
|
CA2161351C
(en)
|
1993-04-26 |
2010-12-21 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
AU693097B2
(en)
|
1993-06-04 |
1998-06-25 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Method for treating kaposi's sarcoma with antisense oligonucleotides
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US6274711B1
(en)
*
|
1993-06-14 |
2001-08-14 |
Inserm, Institut National De La Sante Et De La Recherche Medicale |
Purified mammalian CTLA-8 antigens and related reagents
|
US5830877A
(en)
|
1993-08-26 |
1998-11-03 |
The Regents Of The University Of California |
Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
EP0745134A1
(en)
|
1994-02-22 |
1996-12-04 |
Danafarber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
US5444047A
(en)
*
|
1994-06-16 |
1995-08-22 |
Dipasquale; Gene |
Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I
|
WO2000073452A2
(en)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US5643763A
(en)
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
JP4373495B2
(ja)
*
|
1995-03-23 |
2009-11-25 |
イミュネックス・コーポレーション |
Il−17受容体
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
US5573762A
(en)
*
|
1995-04-24 |
1996-11-12 |
Genentech, Inc. |
Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
US6902735B1
(en)
*
|
1995-07-19 |
2005-06-07 |
Genetics Institute, Llc |
Antibodies to human IL-17F and other CTLA-8-related proteins
|
US6074849A
(en)
|
1995-07-19 |
2000-06-13 |
Genetics Institute, Inc. |
Polynucleotides encoding human CTLA-8 related proteins
|
WO1997004097A2
(en)
|
1995-07-19 |
1997-02-06 |
Genetics Institute, Inc. |
Human ctla-8 and uses of ctla-8-related proteins
|
DK0843961T3
(da)
|
1995-08-29 |
2007-05-21 |
Kirin Brewery |
Kimærisk mus og fremgangsmåde til at producere samme
|
WO1997020062A1
(en)
|
1995-12-01 |
1997-06-05 |
University Of Massachusetts |
Il-12 p40 subunit fusion polypeptides and uses thereof
|
AU728777B2
(en)
|
1996-01-11 |
2001-01-18 |
Corixa Corporation |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US6025130A
(en)
|
1996-04-04 |
2000-02-15 |
Mercator Genetics, Inc. |
Hereditary hemochromatosis gene
|
WO2002008284A2
(en)
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
DE69739375D1
(de)
|
1996-11-27 |
2009-06-04 |
Immunex Corp |
Verfahren zur regulierung der stickstoffmonoxid-erzeugung
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
US6054559A
(en)
*
|
1997-01-28 |
2000-04-25 |
Smithkline Beecham Corporation |
Interleukin-1 receptor antagonist beta (IL-1raβ)
|
US6569645B2
(en)
*
|
1999-05-14 |
2003-05-27 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US20020177188A1
(en)
*
|
1998-05-15 |
2002-11-28 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US6579520B2
(en)
*
|
1998-05-15 |
2003-06-17 |
Genentech, Inc. |
IL-17 related mammalian cytokine polypeptides (IL-17E)
|
CA2288360A1
(en)
|
1997-04-25 |
1998-11-05 |
Zymogenetics, Inc. |
Mammalian cytokine-like factor 7
|
AU8571198A
(en)
|
1997-07-16 |
1999-02-10 |
Human Genome Sciences, Inc. |
Interleukin-20
|
PE20000183A1
(es)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
Citoquinas de mamiferos y reactivos relacionados
|
US6060284A
(en)
*
|
1997-07-25 |
2000-05-09 |
Schering Corporation |
DNA encoding interleukin-B30
|
US6635443B1
(en)
|
1997-09-17 |
2003-10-21 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
|
US6482923B1
(en)
|
1997-09-17 |
2002-11-19 |
Human Genome Sciences, Inc. |
Interleukin 17-like receptor protein
|
US6562578B1
(en)
*
|
1999-01-11 |
2003-05-13 |
Schering Corporation |
IL-17-like cytokine binding compounds and antibodies
|
KR100558288B1
(ko)
|
1997-12-19 |
2006-03-10 |
와이어쓰 |
연골의 퇴행성 질환용 트랜스제닉 동물 모델
|
WO1999032632A1
(en)
|
1997-12-19 |
1999-07-01 |
Millennium Pharmaceuticals, Inc. |
Novel embryo-derived interleukin related factor molecules and uses therefor
|
AU2031399A
(en)
|
1998-01-09 |
1999-07-26 |
Immunex Corporation |
Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
|
ES2312205T3
(es)
|
1998-03-10 |
2009-02-16 |
Genentech, Inc. |
Nuevo polipeptido y acidos nucleicos que lo codifican.
|
ATE325815T1
(de)
|
1998-03-25 |
2006-06-15 |
Genentech Inc |
Menschliches neurotrimin-homolog
|
JP2002510644A
(ja)
|
1998-04-03 |
2002-04-09 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物
|
US7771719B1
(en)
*
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
US20050147609A1
(en)
|
1998-05-15 |
2005-07-07 |
Genentech, Inc. |
Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis
|
JP3577586B2
(ja)
*
|
1998-05-15 |
2004-10-13 |
ジェネンテック・インコーポレーテッド |
Il−17相同的ポリペプチドとその治療用途
|
US20010023070A1
(en)
*
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
EP1082433A4
(en)
*
|
1998-05-29 |
2003-01-02 |
Human Genome Sciences Inc |
Interleukins 21 and 22
|
EP1443055A3
(en)
|
1998-05-29 |
2005-06-08 |
Human Genome Sciences, Inc. |
Interleukins-21 and 22
|
CA2343569C
(en)
|
1998-09-17 |
2010-09-14 |
Zymogenetics, Inc. |
Mammalian transforming growth factor beta - 9
|
AU6277799A
(en)
|
1998-10-02 |
2000-04-26 |
Eli Lilly And Company |
Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
|
JP2000186046A
(ja)
|
1998-10-14 |
2000-07-04 |
Snow Brand Milk Prod Co Ltd |
慢性関節リウマチ治療剤及び診断方法
|
AU3207000A
(en)
|
1999-01-11 |
2000-08-01 |
Schering Corporation |
Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
|
EP1141297B1
(en)
|
1999-01-11 |
2009-09-30 |
Schering Corporation |
Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
|
AU2596700A
(en)
|
1999-03-08 |
2000-09-28 |
Genentech Inc. |
Promotion or inhibition of angiogenesis and cardiovascularization
|
US6914128B1
(en)
*
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
IL145134A0
(en)
|
1999-03-25 |
2002-06-30 |
Knoll Gmbh |
Human antibodies that bind human il-12 and methods for producing
|
AU3632600A
(en)
|
1999-05-14 |
2000-12-05 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20030082734A1
(en)
*
|
1999-06-01 |
2003-05-01 |
Dowling Lynette M. |
Mammalian receptor proteins; related reagents and methods
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
US20030199041A1
(en)
*
|
1999-07-07 |
2003-10-23 |
Presnell Scott R. |
Interleukin-17 receptor homologue
|
ES2364086T3
(es)
|
1999-07-07 |
2011-08-24 |
Zymogenetics, Inc. |
Receptor de citoquina humana.
|
AU7680300A
(en)
|
1999-08-18 |
2001-03-13 |
Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
Human dna sequences
|
EP1208202A2
(en)
|
1999-09-01 |
2002-05-29 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU7099200A
(en)
|
1999-09-03 |
2001-04-10 |
Human Genome Sciences, Inc. |
52 human secreted proteins
|
AU7445900A
(en)
*
|
1999-09-27 |
2001-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor protein, nr12
|
AU3434601A
(en)
|
1999-11-30 |
2001-06-12 |
Genentech Inc. |
Compositions and methods for the treatment of immune related diseases
|
ATE519847T1
(de)
|
1999-12-23 |
2011-08-15 |
Genentech Inc |
Il-17-homologe polypeptide und ihre therapeutische verwendung
|
US20040043397A1
(en)
*
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
EP1254221A2
(en)
|
2000-01-06 |
2002-11-06 |
Protegene Inc. |
HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
|
EP1285084A1
(en)
|
2000-01-25 |
2003-02-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
AU2001229508A1
(en)
|
2000-01-31 |
2001-08-07 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
WO2001057202A2
(en)
|
2000-02-04 |
2001-08-09 |
The Board Of Trustees Of The University Of Arkansas |
Evi27 gene sequences and protein encoded thereby
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AR028256A1
(es)
|
2000-03-16 |
2003-04-30 |
Amgen Inc |
Moleculas similares a receptores il-17 y usos de las mismas
|
AR030554A1
(es)
|
2000-03-16 |
2003-08-27 |
Amgen Inc |
Moleculas similares a receptores il-17 y usos de las mismas
|
US7094566B2
(en)
*
|
2000-03-16 |
2006-08-22 |
Amgen Inc., |
IL-17 receptor like molecules and uses thereof
|
WO2001072323A2
(en)
*
|
2000-03-24 |
2001-10-04 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
EP2020239A1
(en)
|
2000-04-18 |
2009-02-04 |
Schering Corporation |
Use of IL-174 agonists for treating infectious diseases
|
US7422743B2
(en)
*
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
SK287984B6
(sk)
|
2000-05-10 |
2012-08-06 |
Schering Corporation |
Substantially pure or recombinant polypeptide, nucleic acid, host cell, method for the preparation of polypeptide, binding compound, kit, composition comprising an antibody and use thereof
|
JP2003534013A
(ja)
|
2000-05-24 |
2003-11-18 |
シェーリング コーポレイション |
哺乳動物レセプタータンパク質;関連試薬および方法
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030096969A1
(en)
*
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2004504064A
(ja)
|
2000-06-22 |
2004-02-12 |
アムジエン・インコーポレーテツド |
Il−17分子およびその用途
|
EP1309620A2
(en)
|
2000-06-23 |
2003-05-14 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CA2416456A1
(en)
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2001277980A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Zymogenetics Inc. |
Human cytokine receptor
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
JP2002139499A
(ja)
*
|
2000-08-23 |
2002-05-17 |
Sanyo Electric Co Ltd |
化学物質センサおよび化学物質の検出方法
|
JP2002076897A
(ja)
*
|
2000-08-29 |
2002-03-15 |
Toshiba Corp |
Daコンバータ
|
US20070160576A1
(en)
*
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
AU2002324625B2
(en)
*
|
2001-08-07 |
2008-05-08 |
Immunex Corporation |
Interleukin-1 receptors in the treatment of diseases
|
CA2421692A1
(en)
*
|
2002-03-12 |
2003-09-12 |
David J. Pisani |
Disposable bedding with absorbent region
|
WO2004042009A2
(en)
*
|
2002-10-30 |
2004-05-21 |
Genentech, Inc. |
Inhibition of il-17 production
|
DK1601694T3
(da)
*
|
2003-03-10 |
2009-12-14 |
Schering Corp |
Anvendelser af IL23-antagonister, relaterede reagenser
|
DE602004030341D1
(de)
|
2003-06-23 |
2011-01-13 |
Genetics Inst Llc |
Antikörper gegen interleukin-22 und verwendungen dafür
|
EP1641822B1
(en)
*
|
2003-07-08 |
2013-05-15 |
Genentech, Inc. |
Il-17 a/f heterologous polypeptides and therapeutic uses thereof
|
AU2004289304A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Pyridine compounds
|
AU2004289303A1
(en)
*
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
EP1983000B1
(en)
|
2003-11-21 |
2015-09-02 |
UCB Biopharma SPRL |
Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
|
BRPI0507794A
(pt)
*
|
2004-02-17 |
2007-07-17 |
Schering Corp |
métodos de modular a atividade de il-23, reagentes relacionados
|
US20050287593A1
(en)
*
|
2004-05-03 |
2005-12-29 |
Schering Corporation |
Use of cytokine expression to predict skin inflammation; methods of treatment
|
JP2007535930A
(ja)
|
2004-05-03 |
2007-12-13 |
シェーリング コーポレイション |
皮膚の炎症を予測するためのil−17発現の使用;処置方法
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
AR051444A1
(es)
*
|
2004-09-24 |
2007-01-17 |
Centocor Inc |
Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
|
GB0425569D0
(en)
|
2004-11-19 |
2004-12-22 |
Celltech R&D Ltd |
Biological products
|
AU2006214473A1
(en)
*
|
2005-02-14 |
2006-08-24 |
Wyeth |
Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
|
US7858843B2
(en)
|
2005-06-06 |
2010-12-28 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
JP2009507023A
(ja)
|
2005-09-01 |
2009-02-19 |
シェーリング コーポレイション |
自己免疫性眼炎症性疾患を処置するためのil−23およびil−17のアンタゴニストの使用
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
PL2481753T3
(pl)
|
2005-12-13 |
2018-09-28 |
Eli Lilly And Company |
Przeciwciała anty-IL-17
|
WO2007117749A2
(en)
|
2006-01-31 |
2007-10-18 |
Novartis Ag |
Il-17 antagonistic antibodies fpr treating cancer
|
CA2646478A1
(en)
*
|
2006-03-10 |
2007-09-20 |
Zymogenetics, Inc. |
Antibodies that bind both il-17a and il-17f and methods of using the same
|
US7790163B2
(en)
*
|
2006-03-10 |
2010-09-07 |
Zymogenetics, Inc. |
Antibodies that bind both IL-17A and IL-17F and methods of using the same
|
US7790862B2
(en)
|
2006-06-13 |
2010-09-07 |
Zymogenetics, Inc. |
IL-17 and IL-23 antagonists and methods of using the same
|
TW200815469A
(en)
|
2006-06-23 |
2008-04-01 |
Astrazeneca Ab |
Compounds
|
GB0612928D0
(en)
|
2006-06-29 |
2006-08-09 |
Ucb Sa |
Biological products
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
GB0620729D0
(en)
|
2006-10-18 |
2006-11-29 |
Ucb Sa |
Biological products
|
EP2150564A2
(en)
*
|
2007-04-27 |
2010-02-10 |
ZymoGenetics, Inc. |
Antagonists to il-17a, il-17f, and il-23p19 and methods of use
|
WO2008133684A1
(en)
*
|
2007-04-27 |
2008-11-06 |
Zymogenetics, Inc. |
Antibodies that bind both il-17a and il-17f and methods of using the same
|
ES2614735T3
(es)
|
2007-07-23 |
2017-06-01 |
Janssen Biotech, Inc. |
Métodos y composiciones para tratar los trastornos relacionados con fibrosis usando antagonistas de la IL-17
|
WO2009026412A1
(en)
|
2007-08-21 |
2009-02-26 |
Children's Medical Center Corporation |
Treatment of airway hyperreactivity
|
WO2009082624A2
(en)
*
|
2007-12-10 |
2009-07-02 |
Zymogenetics, Inc. |
Antagonists of il-17a, il-17f, and il-23 and methods of using the same
|
GB0807413D0
(en)
|
2008-04-23 |
2008-05-28 |
Ucb Pharma Sa |
Biological products
|
WO2009136286A2
(en)
*
|
2008-05-05 |
2009-11-12 |
Novimmune Sa |
Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
|
US8790642B2
(en)
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
ES2493042T3
(es)
|
2008-09-29 |
2014-09-11 |
Roche Glycart Ag |
Anticuerpos contra la IL-17 humana y usos de los mismos
|
NZ594514A
(en)
|
2009-03-05 |
2013-06-28 |
Abbott Lab |
Interleukin-17 BINDING PROTEINS
|
WO2010128407A2
(en)
*
|
2009-05-05 |
2010-11-11 |
Novimmune S.A. |
Anti-il-17f antibodies and methods of use thereof
|
ES2728115T3
(es)
|
2009-10-30 |
2019-10-22 |
Janssen Biotech Inc |
Antagonistas de IL-17A
|